Chongqing Sintaho Pharmaceutical Co., Ltd.

With one FDA-registered factory and two R&D centers, Sintaho leverages platforms in high-potency small molecules, XDC components and polypeptides to supply chemical synthesis APIs for oncology, metabolism and nervous system therapeutic areas to proprietary and generic drug companies and signatory customers.